Donate
MenuClose

FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy

by | Dec 9, 2020 | Controversies, Ivermectin, Repurposed Drugs

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362818/

Originally published by:  Science Direct

Author: Drożdżal S, Rosik J, Lechowicz K, et al.

Date: 12/2020

Categories: Integrative Therapies,Treatment,Ivermectin

Comments

0 Comments

Submit a Comment

Find more articles